Cost-Effectiveness Analysis Of Bemiparin Used As Acute Treatment For Deep Venous Thrombosis Without Pulmonary Embolism

Deep venous thrombosis (DVT) and pulmonary embolism (PE) comprise venous thromboembolism (VTE), the third most common cardiovascular illness after acute coronary syndrome and stroke and a raising public health concern due to its morbity and mortality and higher costs. Acute and long term treatments help to avoid complications. We assessed the costs and effectiveness of different regimens for treatment of DVT without PE under the perspective of the Mexican public health system.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: A Aguirre, F Carlos, M Naranjo, C Fernandez Source Type: research